Citations (33)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Massimo Breccia & Giuliana Alimena. (2010) NF-κB as a potential therapeutic target in myelodysplastic syndromes and acute myeloid leukemia. Expert Opinion on Therapeutic Targets 14:11, pages 1157-1176.
Read now
Read now
Basem M. William, Ami Goodrich, Cong Peng & Shaoguang Li. (2008) Curcumin inhibits proliferation and induces apoptosis of leukemic cells expressing wild-type or T315I-BCR-ABL and prolongs survival of mice with acute lymphoblastic leukemia. Hematology 13:6, pages 333-343.
Read now
Read now
Articles from other publishers (31)
Ming Guan Ng, Khuen Yen Ng, Rhun Yian Koh & Soi Moi Chye. (2021) Potential role of melatonin in prevention and treatment of leukaemia. Hormone Molecular Biology and Clinical Investigation 42:4, pages 445-461.
Crossref
Crossref
Chris Pepper & Chris Fegan. 2018. Small-molecule Transcription Factor Inhibitors in Oncology. Small-molecule Transcription Factor Inhibitors in Oncology
125
146
.
Qinghua Jia, Huiyan Sun, Fengjun Xiao, Yan Sai, Qingfang Li, Xiaoyan Zhang, Shuang Yang, Hengxiang Wang, Hua Wang, Yuefeng Yang, Chu-Tse Wu & Lisheng Wang. (2017) miR-17-92 promotes leukemogenesis in chronic myeloid leukemia via targeting A20 and activation of NF-κB signaling. Biochemical and Biophysical Research Communications 487:4, pages 868-874.
Crossref
Crossref
Prudhvi Lal Bhukya, Rongala Laxmivandana & Gopinath Meenakshi Sundaram. 2017. Role of Transcription Factors in Gastrointestinal Malignancies. Role of Transcription Factors in Gastrointestinal Malignancies
45
71
.
Giovanna Carrà, Davide Torti, Sabrina Crivellaro, Cristina Panuzzo, Riccardo Taulli, Daniela Cilloni, Angelo Guerrasio, Giuseppe Saglio & Alessandro Morotti. (2016) The BCR-ABL/NF-κB signal transduction network: a long lasting relationship in Philadelphia positive Leukemias. Oncotarget 7:40, pages 66287-66298.
Crossref
Crossref
Jessika Bertacchini, Neda Ketabchi, Laura Mediani, Silvano Capitani, Sandra Marmiroli & Najmaldin Saki. (2015) Inhibition of Ras-mediated signaling pathways in CML stem cells. Cellular Oncology 38:6, pages 407-418.
Crossref
Crossref
Xinli Liu, Jun Zhang, Jing Li, Andrew Volk, Peter Breslin, Jiwang Zhang & Zhou Zhang. (2014) The Synergistic Repressive Effect of NF-κB and JNK Inhibitor on the Clonogenic Capacity of Jurkat Leukemia Cells. PLoS ONE 9:12, pages e115490.
Crossref
Crossref
Mo-Ying Hsieh & Richard A. Van Etten. (2014) IKK-dependent activation of NF-κB contributes to myeloid and lymphoid leukemogenesis by BCR-ABL1. Blood 123:15, pages 2401-2411.
Crossref
Crossref
Janusz Krawczyk, Michael O’Dwyer, Ronan Swords, Ciara Freeman & Francis J Giles. 2014. Inflammation and Cancer. Inflammation and Cancer
335
360
.
Ido Paz-Priel & Alan D. Friedman. 2015. Molecular Oncology. Molecular Oncology
777
785
.
Jos? E. V?zquez-Franco, Elba Reyes-Maldonado, Jorge Vela-Ojeda, Maria L. Dom?nguez-L?pez & Ruth A. Lezama. (2012) Src, Akt, NF-?B, BCL-2 and c-IAP1 may be involved in an anti-apoptotic effect in patients with BCR-ABL positive and BCR-ABL negative acute lymphoblastic leukemia. Leukemia Research 36:7, pages 862-867.
Crossref
Crossref
Cagatay Oktenli & Serkan Celik. (2012) High frequency of inherited variants in the MEFV gene in patients with hematologic neoplasms: a genetic susceptibility?. International Journal of Hematology 95:4, pages 380-385.
Crossref
Crossref
Naveed I. Khan, Adam Cisterne, Rana Baraz, Kenneth F. Bradstock & Linda J. Bendall. (2012) Para-NO-aspirin inhibits NF-κB and induces apoptosis in B-cell progenitor acute lymphoblastic leukemia. Experimental Hematology 40:3, pages 207-215.e1.
Crossref
Crossref
Hui‐Jen Tsai, Seiichiro Kobayashi, Kiyoko Izawa, Takaomi Ishida, Toshiki Watanabe, Kazuo Umezawa, Sheng‐Fung Lin & Arinobu Tojo. (2011) Bioimaging analysis of nuclear factor‐κB activity in Philadelphia chromosome‐positive acute lymphoblastic leukemia cells reveals its synergistic upregulation by tumor necrosis factor‐α‐stimulated changes to the microenvironment. Cancer Science 102:11, pages 2014-2021.
Crossref
Crossref
Clare Pridans & Brian J. P. Huntly. 2011. New Agents for the Treatment of Acute Lymphoblastic Leukemia. New Agents for the Treatment of Acute Lymphoblastic Leukemia
143
166
.
Reshmi Parameswaran, Markus Müschen, Yong-mi Kim, John Groffen & Nora Heisterkamp. (2010) A Functional Receptor for B-Cell–Activating Factor Is Expressed on Human Acute Lymphoblastic Leukemias. Cancer Research 70:11, pages 4346-4356.
Crossref
Crossref
Sahdeo Prasad, Jayaraj Ravindran & Bharat B. Aggarwal. (2009) NF-κB and cancer: how intimate is this relationship. Molecular and Cellular Biochemistry 336:1-2, pages 25-37.
Crossref
Crossref
Lenny Dang. 2009. Enzyme Inhibition in Drug Discovery and Development. Enzyme Inhibition in Drug Discovery and Development
569
623
.
Chris PepperSaman HewamanaPaul BrennanChris Fegan. (2009) NF-κB as a prognostic marker and therapeutic target in chronic lymphocytic leukemia. Future Oncology 5:7, pages 1027-1037.
Crossref
Crossref
Bharat B Aggarwal & Prashasnika Gehlot. (2009) Inflammation and cancer: how friendly is the relationship for cancer patients?. Current Opinion in Pharmacology 9:4, pages 351-369.
Crossref
Crossref
Graham Packham. (2008) The role of NF-κB in lymphoid malignancies. British Journal of Haematology 143:1, pages 3-15.
Crossref
Crossref
Guadalupe Martínez-Jaramillo, Jorge Vela-Ojeda, Elizabeth Sánchez-Valle, Juan José Montesinos & Hector Mayani. (2007) In vitro functional alterations in the hematopoietic system of adult patients with acute lymphoblastic leukemia. Leukemia Research 31:1, pages 83-89.
Crossref
Crossref
D S Bassères & A S Baldwin. (2006) Nuclear factor-κB and inhibitor of κB kinase pathways in oncogenic initiation and progression. Oncogene 25:51, pages 6817-6830.
Crossref
Crossref
J Dutta, Y Fan, N Gupta, G Fan & C Gélinas. (2006) Current insights into the regulation of programmed cell death by NF-κB. Oncogene 25:51, pages 6800-6816.
Crossref
Crossref
Hongyu LiuChuanbing ZangMartin H. FennerDachuan LiuKurt PossingerH. Phillip KoefflerElena Elstner. (2006) Growth inhibition and apoptosis in human Philadelphia chromosome-positive lymphoblastic leukemia cell lines by treatment with the dual PPARα/γ ligand TZD18. Blood 107:9, pages 3683-3692.
Crossref
Crossref
H J Kim, N Hawke & A S Baldwin. (2006) NF-κB and IKK as therapeutic targets in cancer. Cell Death & Differentiation 13:5, pages 738-747.
Crossref
Crossref
T Braun, G Carvalho, C Fabre, J Grosjean, P Fenaux & G Kroemer. (2006) Targeting NF-κB in hematologic malignancies. Cell Death & Differentiation 13:5, pages 748-758.
Crossref
Crossref
Elaine J. Schattner, Richard R. Furman & Alejandro Bernal. 2006. NF-κB/Rel Transcription Factor Family. NF-κB/Rel Transcription Factor Family
131
146
.
Arndt J. Schottelius & Harald Dinter. 2006. The Link Between Inflammation and Cancer. The Link Between Inflammation and Cancer
67
87
.
Hideyasu Miura, Michiyuki Maeda, Naoki Yamamoto & Shoji Yamaoka. (2005) Distinct IκB kinase regulation in adult T cell leukemia and HTLV-I-transformed cells. Experimental Cell Research 308:1, pages 29-40.
Crossref
Crossref
Michael G. Kharas & David A. Fruman. (2005)
ABL
Oncogenes and Phosphoinositide 3-Kinase: Mechanism of Activation and Downstream Effectors
. Cancer Research 65:6, pages 2047-2053.
Crossref
Crossref